Condition: Cardiovascular Diseases · Heart Diseases · Heart Failure · Sponsor: BrioHealth Solutions, Inc.
The goal of this study is to evaluate the safety and efficacy of the BrioVAD System by demonstrating non-inferiority to the HeartMate 3 Left Ventricular Assist System when used for the treatment of advanced, refractory, left ventricular heart failure.
This description comes directly from the study's public registry record.
Pranesh Thirukkonda · 12014016539 · pranesh.thirukkonda@briohealth.com
Lynda McMahon · 15085252203 · lynda.mcmahon@briohealth.com
Always discuss trial participation with your own doctor first.
| Baptist Health Medical Center-Little Rock | Little Rock, Arkansas, United States | Recruiting |
| UF Health Shands Hospital | Gainsville, Florida, United States | Recruiting |
| Advent Health | Orlando, Florida, United States | Recruiting |
| Piedmont Healthcare | Atlanta, Georgia, United States | Recruiting |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| Advocate Christ Medical Center | Chicago, Illinois, United States | Recruiting |
| Northwestern University | Chicago, Illinois, United States | Recruiting |
| University of Chicago | Chicago, Illinois, United States | Recruiting |
| Ascension St. Vincent Hospital - Indianapolis | Indianapolis, Indiana, United States | Recruiting |
| University of Louisville | Louisville, Kentucky, United States | Recruiting |
| University of Maryland Medical Center | Baltimore, Maryland, United States | Recruiting |
| Tufts Medical Center | Boston, Massachusetts, United States | Recruiting |
+ 25 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06310031